Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 1999
by FDA Office of Orphan Products Development.
Recruitment status was Active, not recruiting
Study NCT00004690 Information provided by FDA Office of Orphan Products Development
First Received on February 24, 2000. Last Updated on June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ichthyosis
Additional conditions recognized in this trial
Ichthyosis, Lamellar
More general conditions related to this trial
Congenital Abnormalities
Genetic Diseases, Inborn
Ichthyosiform Erythroderma, Congenital
Infant, Newborn, Diseases
Keratosis
Skin Abnormalities
Skin Diseases
Skin Diseases, Genetic
Interventions listed in this trial
monolaurin cream
Additional drug interventions recognized in this trial
Monolaurin
More general drug interventions related to this trial
Cariostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
FDA Office of Orphan Products Development
Cellegy Pharmaceuticals
Back to top of Main Content